#United States #New York #Class Action #Corcept Therapeutics #CORT lawsuit

Corcept Therapeutics Shareholder Alert

The Gross Law Firm has issued a significant notice for shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT). This notice is primarily directed at those who have purchased shares within the designated class period, which spans from October 31, 2024, to December 30, 2025. As the deadline for appointing a lead plaintiff is set for April 21, 2026, affected shareholders are encouraged to act promptly.

Background of the Lawsuit

The allegations stemmed from disclosures that the defendants allegedly made false statements and withheld critical information. Specifically, it has been reported that the FDA had raised concerns regarding Corcept's program assessing the effectiveness of relacorilant to treat hypertension in patients suffering from hypercortisolism. The design of the GRACE study specifically came under scrutiny, indicating that significant issues would arise if Corcept moved forward with the NDA submission. Consequently, statements made by the defendants about their interactions with the FDA and expectations for the relacorilant NDA approval were, according to the lawsuit, materially misleading.

Why You Should Act

For shareholders of CORT, immediate action is crucial. Those wishing to participate in the upcoming proceedings should register before the lead plaintiff deadline of April 21, 2026. The Gross Law Firm emphasizes that enrolling in this class action has no financial obligations for the shareholders. Furthermore, once registered, shareholders will benefit from a portfolio monitoring software that will keep them informed about the case's developments.

Next Steps for Shareholders

If you are a shareholder who acquired shares during the specified time frame, it is imperative to register your information as soon as possible. Registration ensures that shareholders can secure their position if they choose to pursue recovery and will also keep them updated about the lawsuit's progress.

To register, interested parties are directed to visit the provided link: Register Here.

Who is The Gross Law Firm?

The Gross Law Firm is a well-respected class action law firm that focuses on protecting investors' rights. Their commitment lies in addressing the consequences suffered by investors due to deceptive, fraudulent, and illegal practices. The firm stands firm on the principle that companies must adhere to responsible business practices and ensures they are held accountable. With their experience, they seek recovery on behalf of investors negatively impacted by false or misleading information that resulted in inflated stock prices.

Contact Information

Shareholders or potential claimants are encouraged to reach out to The Gross Law Firm for further guidance. The firm can be contacted at:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

As the class action lawsuit progresses, it promises to be a significant development for Corcept Therapeutics investors, and taking timely action is paramount.